PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14619584-0	2003	[Effects of cilazapril on the expression of vascular endothelial growth factor and intercellular adhesion molecule-1 in diabetic rat glomeruli].	Cilazapril	12-22	intercellular adhesion molecule 1	Rattus norvegicus	83-116	
14619584-1	2003	OBJECTIVE: To assess the effect of cilazapril, an angiotensin-converting enzyme inhibitor (ACEI), on the protection against diabetic nephropathy and on the expression of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli.	Cilazapril	35-45	intercellular adhesion molecule 1	Rattus norvegicus	216-249	
14619584-1	2003	OBJECTIVE: To assess the effect of cilazapril, an angiotensin-converting enzyme inhibitor (ACEI), on the protection against diabetic nephropathy and on the expression of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli.	Cilazapril	35-45	intercellular adhesion molecule 1	Rattus norvegicus	251-257	
14619584-6	2003	Cilazapril could reduce KW/BW, CCr and 24 hours urine protein count and significantly suppress the overexpression of VEGF and ICAM-1 in cilazapril treatment group after 8 weeks, compared with the DM model group(P < 0.05).	Cilazapril	0-10	intercellular adhesion molecule 1	Rattus norvegicus	126-132	
14619584-6	2003	Cilazapril could reduce KW/BW, CCr and 24 hours urine protein count and significantly suppress the overexpression of VEGF and ICAM-1 in cilazapril treatment group after 8 weeks, compared with the DM model group(P < 0.05).	Cilazapril	136-146	intercellular adhesion molecule 1	Rattus norvegicus	126-132	
14619584-7	2003	CONCLUSION: Cilazapril can suppress the overproduction of two cytokines, VEGF and ICAM-1, thus preventing the progression of diabetic nephropathy.	Cilazapril	12-22	intercellular adhesion molecule 1	Rattus norvegicus	82-88